Outcomes of acute phase cognitive therapy in outpatients with anxious versus nonanxious depression

Psychotherapy and Psychosomatics

Volumn 81, Issue 3, 2012, Pages 153-160

  Smits, Jasper A J ^a   Minhajuddin, Abu ^b   Thase, Michael E ^c,d,e   Jarrett, Robin B ^b  

^a SOUTHERN METHODIST UNIVERSITY   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

^e UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Anxious depression; Cognitive therapy; Major depressive disorder; Treatment outcome

Indexed keywords

ADULT; ANXIETY DISORDER; ANXIOUS MAJOR DEPRESSION; ARTICLE; COGNITIVE THERAPY; DISEASE SEVERITY; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MENTAL PATIENT; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT PARTICIPATION; PRIORITY JOURNAL; RECURRENT DISEASE; REMISSION; SELF REPORT; TIME; TREATMENT RESPONSE;

ADULT; AMBULATORY CARE; ANXIETY; ANXIETY DISORDERS; COGNITIVE THERAPY; COMORBIDITY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INTERVIEW, PSYCHOLOGICAL; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; MALE; OUTPATIENTS; PSYCHIATRIC STATUS RATING SCALES; RECURRENCE; REMISSION INDUCTION; SELF REPORT; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME;

EID: 84857702797     PISSN: 00333190     EISSN: 14230348     Source Type: Journal    
DOI: 10.1159/000334909     Document Type: Article

References (30)

1. Davidson JR, Meoni P, Haudiquet V, Cantillon M, Hackett D: Achieving remission with venlafaxine and fluoxetine in major depression: its relationship to anxiety symptoms. Depress Anxiety 2002; 16: 4-13. (Pubitemid 34977120)
2. Fava M, Rush AJ, Alpert JE, Balasubramani GK, Wisniewski SR, Carmin CN, Biggs MM, Zisook S, Leuchter A, Howland R, Warden D, Trivedi MH: Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR * D report. Am J Psychiatry 2008; 165: 342-351. (Pubitemid 351704490)
3. Flint AJ, Rifat SL: Anxious depression in elderly patients: response to antidepressant treatment. Am J Geriatr Psychiatry 1997; 5: 107-115. (Pubitemid 27157394)
4. Wiethoff K, Bauer M, Baghai TC, Moller HJ, Fisher R, Hollinde D, Kiermeir J, Hauth I, Laux G, Cordes J, Brieger P, Kronmuller KT, Zeiler J, Adli M: Prevalence and treatment outcome in anxious versus nonanxious depression: results from the German Algorithm Project. J Clin Psychiatry 2010; 71: 1047-1054.
5. Papakostas GI, McGrath P, Stewart J, Charles D, Chen Y, Mischoulon D, Dording C, Fava M: Psychic and somatic anxiety symptoms as predictors of response to fluoxetine in major depressive disorder. Psychiatry Res 2008; 161: 116-120.
6. Silverstone PH, von Studnitz E: Defining anxious depression: going beyond comorbidity. Can J Psychiatry 2003; 48: 675-680. (Pubitemid 37522540)
7. Fava M, Alpert JE, Carmin CN, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K, Morgan D, Schwartz T, Balasubramani GK, Rush AJ: Clinical correlates and symptom patterns of anxious depression among patients with major depressive disorder in STAR * D. Psychol Med 2004; 34: 1299-1308. (Pubitemid 39517160)
8. Fava M, Rush AJ, Alpert JE, Carmin CN, Balasubramani GK, Wisniewski SR, Trivedi MH, Biggs MM, Shores-Wilson K: What clinical and symptom features and comorbid disorders characterize outpatients with anxious major depressive disorder: a replication and extension. Can J Psychiatry 2006; 51: 823-835. (Pubitemid 46354060)
9. Joffe RT, Bagby RM, Levitt A: Anxious and nonanxious depression. Am J Psychiatry. 1993; 150: 1257-1258. (Pubitemid 23218913)
10. Lichtenberg P, Belmaker RH: Subtyping major depressive disorder. Psychother Psychosom. 2010; 79: 131-135.
11. Harvey A, Watkins E, Mansell W, Shafran R: Cognitive Behavioural Processes across Psychological Disorders: A Transdiagnostic Approach to Research and Treatment. Oxford, Oxford University Press, 2004.
12. Moscovitch DA, Hofmann SG, Suvak MK, In- Albon T: Mediation of changes in anxiety and depression during treatment of social phobia. J Consult Clin Psychol 2005; 73: 945-952. (Pubitemid 41643244)
13. Kuyken W, Byford S, Taylor RS, Watkins E, Holden E, White K, et al: Mindfulness-based cognitive therapy to prevent relapse in recurrent depression. J Consult Clin Psychol 2008; 76: 966-978.
14. Smits JA, Minhajuddin A, Jarrett RB: Cognitive therapy for depressed adults with comorbid social phobia. J Affect Disord 2009; 114: 271-278.
15. Jarrett RB, Thase ME: Comparative efficacy and durability of continuation phase cognitive therapy for preventing recurrent depression: design of a double-blinded, fluoxetineand pill placebo-controlled, randomized trial with 2-year follow-up. Contemp Clin Trials 2010; 31: 355-377.
16. First MB, Spitzer RL, Gibbon M, Williams JB: Structured Clinical Interview for DSMIV Axis I Disorders - Patient Edition (SCIDI/ P, Version 2.0). New York, New York State Psychiatric Institute, Biometrics Research Department, 1996.
17. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960; 23: 56-62.
18. Rush AJ, Giles DE, Schlesser MA, Fulton CL, Weissenburger J, Burns C: The Inventory for Depressive Symptomatology (IDS): preliminary findings. Psychiatry Res 1986; 18: 65-87. (Pubitemid 16085767)
19. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-571.
20. Ninan PT, Rush AJ, Crits-Christoph P, Kornstein SG, Manber R, Thase ME, Trivedi MH, Rothbaum BO, Zajecka J, Borian FE, Keller MB: Symptomatic and syndromal anxiety in chronic forms of major depression: effect of nefazodone, cognitive behavioral analysis system of psychotherapy, and their combination. J Clin Psychiatry 2002; 63: 434-441. (Pubitemid 34507222)
21. Cleary P, Guy W: Factor analysis of the Hamilton Depression Scale. Drugs Exp Clin Res 1977; 1: 115-120.
22. Beck AT, Rush AJ, Shaw BF, Emery G: Cognitive Therapy of Depression. New York, Guilford Press, 1979.
23. Vallis TM, Shaw BF, Dobson KS: The cognitive therapy scale: psychometric properties. J Consult Clin Psychol 1986; 54: 381-385. (Pubitemid 17105982)
24. Jarrett RB, Kraft D, Doyle J, Foster BM, Eaves GG, Silver PC: Preventing recurrent depression using cognitive therapy with and without a continuation phase: a randomized clinical trial. Arch Gen Psychiatry 2001; 58: 381-388. (Pubitemid 32299534)
25. Thase ME, Simons AD, McGeary J, Cahalane JF, Hughes C, Harden T, Friedman E: Relapse after cognitive behavior therapy of depression: potential implications for longer courses of treatment. Am J Psychiatry 1992; 149: 1046-1052.
26. Thase ME, Simons AD, Reynolds CF 3rd: Abnormal electroencephalographic sleep profiles in major depression: association with response to cognitive behavior therapy. Arch Gen Psychiatry 1996; 53: 99-108. (Pubitemid 26049386)
27. Ferster CB: A functional analysis of depression. Am Psychol 1973; 28: 857-870.
28. Fava GA, Tomba E: New modalities of assessment and treatment planning in depression: the sequential approach. CNS Drugs 2010; 24: 453-465.
29. Mergl R, Henkel V, Allgaier AK, Kramer D, Hautzinger M, Kohnen R, Coyne J, Hegerl U: Are treatment preferences relevant in response to serotonergic antidepressants and cognitive-behavioral therapy in depressed primary care patients? Results from a randomized controlled trial including a patients' choice arm. Psychother Psychosom 2011; 80: 39-47.
30. Jarrett RB, Vittengl JR, Clark LA: How much cognitive therapy, for which patients, will prevent depressive relapse? J Affect Disord 2008; 111: 185-192.